Bank Of America Corp Fortress Biotech, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.49 - $0.82 $836 - $1,400	-1,708 Reduced 10.8%	14,114 $7,000
Q1 2023 May 12, 2023	SELL	$0.65 - $1.1 $13,877 - $23,485	-21,350 Reduced 57.44%	15,822 $12,000
Q4 2022 Feb 10, 2023	BUY	$0.48 - $13.5 $3,074 - $86,467	6,405 Added 20.82%	37,172 $24,000
Q3 2022 Nov 14, 2022	BUY	$0.79 - $22.0 $18,124 - $504,746	22,943 Added 293.24%	30,767 $26,000
Q2 2022 Aug 12, 2022	SELL	$0.8 - $1.5 $1,980 - $3,714	-2,476 Reduced 24.04%	7,824 $6,000
Q1 2022 May 16, 2022	SELL	$1.24 - $2.75 $148,612 - $329,584	-119,849 Reduced 92.09%	10,300 $14,000
Q4 2021 Feb 08, 2022	BUY	$2.42 - $3.65 $52,726 - $79,526	21,788 Added 20.11%	130,149 $326,000
Q3 2021 Nov 15, 2021	BUY	$2.82 - $3.7 $5,716 - $7,499	2,027 Added 1.91%	108,361 $349,000
Q2 2021 Sep 13, 2021	BUY	$3.5 - $5.48 $372,169 - $582,710	106,334 New	106,334 $379,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $155M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.